| Primary |
| Type 1 Diabetes Mellitus |
40.0% |
| Arthralgia |
20.0% |
| Diabetes Mellitus |
20.0% |
| Hiv Infection |
20.0% |
|
| Hyperglycaemia |
16.7% |
| Hypoglycaemia |
16.7% |
| Hypoglycaemic Seizure |
16.7% |
| Rash |
16.7% |
| Renal Failure Acute |
16.7% |
| Skin Reaction |
16.7% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
25.3% |
| Diabetes Mellitus |
9.4% |
| Pain |
8.8% |
| Product Used For Unknown Indication |
5.1% |
| Blood Pressure Increased |
4.9% |
| Helicobacter Infection |
4.1% |
| Suicide Attempt |
3.9% |
| Hypertension |
3.5% |
| Drug Use For Unknown Indication |
3.1% |
| Constipation |
2.9% |
| Depression |
2.9% |
| Fibromyalgia |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Myalgia |
2.9% |
| Nasal Septum Deviation |
2.9% |
| Restless Legs Syndrome |
2.9% |
| Sleep Apnoea Syndrome |
2.9% |
| Thyroid Disorder |
2.9% |
| Cardiac Disorder |
2.7% |
| Mood Swings |
2.5% |
|
| Fibromyalgia |
17.7% |
| Hypoglycaemia |
15.2% |
| Renal Failure Acute |
6.3% |
| Blood Glucose Decreased |
5.1% |
| Generalised Anxiety Disorder |
5.1% |
| Intentional Overdose |
5.1% |
| Weight Decreased |
5.1% |
| Glycosylated Haemoglobin Increased |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Osteomyelitis |
3.8% |
| Pelvic Fracture |
3.8% |
| Product Quality Issue |
3.8% |
| Systemic Inflammatory Response Syndrome |
3.8% |
| Blood Glucose Increased |
2.5% |
| Congestive Cardiomyopathy |
2.5% |
| Diarrhoea |
2.5% |
| Drug Dose Omission |
2.5% |
| Drug Ineffective |
2.5% |
| Injection Site Pain |
2.5% |
| Orthostatic Hypotension |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.4% |
| Diabetes Mellitus |
18.7% |
| Drug Use For Unknown Indication |
13.5% |
| Hypertension |
7.9% |
| Type 2 Diabetes Mellitus |
6.8% |
| Pain |
3.8% |
| Type 1 Diabetes Mellitus |
2.8% |
| Graft Versus Host Disease |
2.5% |
| Medical Diet |
2.3% |
| Prophylaxis |
2.2% |
| Constipation |
2.0% |
| Cardiac Failure |
1.5% |
| Back Pain |
1.3% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.3% |
| Neoplasm |
1.3% |
| Depression |
1.2% |
| Infection |
1.2% |
| Acute Lymphocytic Leukaemia |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Coronary Artery Disease |
1.1% |
|
| Vomiting |
11.1% |
| Blood Glucose Increased |
8.2% |
| In-stent Coronary Artery Restenosis |
7.2% |
| Weight Increased |
7.2% |
| Weight Decreased |
6.8% |
| Pyrexia |
6.3% |
| Hypoglycaemia |
5.3% |
| Somnolence |
5.3% |
| Renal Failure |
4.8% |
| Thrombocytopenia |
4.3% |
| Nausea |
3.9% |
| Pneumonia |
3.9% |
| Renal Failure Acute |
3.9% |
| Tremor |
3.4% |
| Urinary Tract Infection |
3.4% |
| Vision Blurred |
3.4% |
| Wheezing |
3.4% |
| International Normalised Ratio Increased |
2.9% |
| Renal Impairment |
2.9% |
| Death |
2.4% |
|
| Interacting |
| Helicobacter Infection |
43.8% |
| Type 2 Diabetes Mellitus |
40.6% |
| Diabetes Mellitus |
4.7% |
| Hypertension |
3.1% |
| Neuralgia |
3.1% |
| Back Pain |
1.6% |
| Restlessness |
1.6% |
| Smoking Cessation Therapy |
1.6% |
|
| Hypoglycaemia |
75.0% |
| Drug Interaction |
8.3% |
| Hyperglycaemia |
8.3% |
| Tinnitus |
8.3% |
|
